2-Nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 98%, 5g

4-Bromo-1-cyclopropyl-1H-pyrazole, 95.0%, 25g

(2-Bromo-6-fluorophenyl)methanol, 95.0%, 100g

(Z)-tert-butyl 2-(1-(4-(Methoxycarbonyl)phenyl)ethylidene)hydrazinecarboxylate, 98%, 100mg

(R,R)-2-Iodo-1,3-bis[1-(mesitylcarbamoyl)ethoxy]benzene>98.0%(HPLC)(NMR)200mg

Ethyl (2R,4R)-4-methyl-2-piperidinecarboxylate, 95.0%, 1g

4-(Azetidin-3-yl)thiomorpholine 1,1-dioxide dihydrochloride, 95.0%, 1g

Imbuto separatore acc. a Gilson, 250 ml, 2 Pezzo(i)

1-{[5-(4-fluorophenyl)-1,3-oxazol-4-yl]methyl}piperidin-4-amine dihydrochloride, 95.0%, 500mg

3-Mercaptohexyl acetate, 95.0%, 25g

2-(tert-Butoxycarbonyl-methyl-amino)-4-chloro-benzoic acid, 97.0%, 1g

(3-Bromo-5-(ethoxycarbonyl)phenyl)boronic acid, 95.0%, 1g

2,4,6-Trichloropyridine-3,5-dicarboxylic acid, 97%, 100mg